Skip to main content
KZIA
NASDAQ Life Sciences

Kazia Therapeutics Triples Patient Enrollment in Phase 1B Breast Cancer Trial

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.71
Mkt Cap
$154.85M
52W Low
$3.3
52W High
$17.4
52W Position info
315% above low
Off High info
21% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

KZIA has more than doubled off its 52-week low of $3.3.

Summary

Kazia Therapeutics is expanding its Phase 1B trial for Paxalisib in advanced breast cancer, increasing planned patient enrollment from 12 to 36. This significant expansion signals progress and commitment to the drug's development. For a small-cap biotech, advancing clinical trials is crucial for future valuation and pipeline strength.

At the time of this announcement, KZIA was trading at $13.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.8M. The 52-week trading range was $3.30 to $17.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

KZIA - Latest Insights

KZIA
Jun 02, 2026, 9:04 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $12.87
Real-time Price: $12.62 info
Change: -$0.250 (-2%) info
Market Cap: $147.141M info
KZIA
Jun 02, 2026, 9:03 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $12.87
Real-time Price: $12.62 info
Change: -$0.250 (-2%) info
Market Cap: $147.141M info
KZIA
Jun 02, 2026, 9:02 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $12.87
Real-time Price: $12.62 info
Change: -$0.250 (-2%) info
Market Cap: $147.141M info
KZIA
Jun 02, 2026, 9:01 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $12.87
Real-time Price: $12.62 info
Change: -$0.250 (-2%) info
Market Cap: $147.141M info
KZIA
Jun 02, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.87
Real-time Price: $12.62 info
Change: -$0.250 (-2%) info
Market Cap: $147.141M info
KZIA
May 26, 2026, 8:03 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $13.95
Real-time Price: $12.62 info
Change: -$1.33 (-10%) info
Market Cap: $147.141M info
KZIA
May 26, 2026, 8:02 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $13.95
Real-time Price: $12.62 info
Change: -$1.33 (-10%) info
Market Cap: $147.141M info
KZIA
May 26, 2026, 8:01 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $13.95
Real-time Price: $12.62 info
Change: -$1.33 (-10%) info
Market Cap: $147.141M info
KZIA
May 26, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.95
Real-time Price: $12.62 info
Change: -$1.33 (-10%) info
Market Cap: $147.141M info
KZIA
May 26, 2026, 7:39 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $13.71
Real-time Price: $12.62 info
Change: -$1.09 (-8%) info
Market Cap: $147.141M info